PH22018000418U1 - Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippines - Google Patents
Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippinesInfo
- Publication number
- PH22018000418U1 PH22018000418U1 PH22018000418U PH22018000418U PH22018000418U1 PH 22018000418 U1 PH22018000418 U1 PH 22018000418U1 PH 22018000418 U PH22018000418 U PH 22018000418U PH 22018000418 U PH22018000418 U PH 22018000418U PH 22018000418 U1 PH22018000418 U1 PH 22018000418U1
- Authority
- PH
- Philippines
- Prior art keywords
- manilae
- vaccines
- philippines
- monovalent
- losbanos
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present technology relates to processes of preparing leptospirosis vaccines against serovars or serotypes of Leptospira prevalent in the Philippines. Three types of inactivated vaccines were developed based on two identified most prevalent pathogenic Leptospira serovars circulating in the Philippines, namely, Manilae and Losbanos. The vaccines that have been developed are: (1) Monovalent Manilae, (2) Monovalent Losbanos, and (3) Bivalent Manilae and Losbanos (homologous challenge with serovars Manilae and Losbanos and heterochallenge with serovar Grippotyphosa and serovar Canicola). The vaccines that were produced through the developed process were assessed on their safety, immunogenicity and efficiency. The main advantage of these vaccines is their serovar-specificity for the pathogenic Leptospira serovars that are locally prevalent which would ensure an effectively directed program of preventive control of leptospirosis in animals which can be translated to effective leptospirosis prevention among humans.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PH22018000418U PH22018000418Y1 (en) | 2018-05-15 | 2018-05-15 | Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PH22018000418U PH22018000418Y1 (en) | 2018-05-15 | 2018-05-15 | Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippines |
Publications (2)
Publication Number | Publication Date |
---|---|
PH22018000418U1 true PH22018000418U1 (en) | 2020-04-22 |
PH22018000418Y1 PH22018000418Y1 (en) | 2020-04-22 |
Family
ID=71112219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH22018000418U PH22018000418Y1 (en) | 2018-05-15 | 2018-05-15 | Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippines |
Country Status (1)
Country | Link |
---|---|
PH (1) | PH22018000418Y1 (en) |
-
2018
- 2018-05-15 PH PH22018000418U patent/PH22018000418Y1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH22018000418Y1 (en) | 2020-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ595914A (en) | Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation | |
PE20140576A1 (en) | BOVINE VACCINES AND METHODS | |
NZ591950A (en) | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition | |
PE20170243A1 (en) | VACCINE COMPOSITIONS WITH DUAL ADJUVANT, PREPARATION AND USES | |
MX2013010620A (en) | Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof. | |
MX2018010958A (en) | Live attenuated zika virus vaccine. | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
BR112015005056A2 (en) | combination vaccines with meningococcus serogroup b and d / t / p | |
CL2016002402A1 (en) | Immunological compositions containing histophilus somni attenuated | |
MX2018015506A (en) | Vaccine against infectious bronchitis virus. | |
PH12018500305A1 (en) | Multivalent vlp conjugates | |
CL2008003845A1 (en) | Vaccine comprising an emulsion, a bacterin heat-treated at 55-70 ° C for 5-10 hours, comprising a suspension of killed bacteria of the leptospira bratislava species, and from 1 to 13 viruses that cause swine disease. | |
PH12018501750A1 (en) | Porcine reproductive and respiratory syndrome vaccine virus | |
BR112016007390A2 (en) | haemophilus parasuis serotype type four vaccine | |
EA201892003A1 (en) | TREATMENT OF ATOPIC DERMATITIS DOGS | |
PH22018000417Y1 (en) | Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines | |
PH22018000416U1 (en) | Bivalent manilae and losbanos vaccine against locally prevalent leptospira serovars in the philippines | |
PH22018000418U1 (en) | Monovalent manilae vaccine against locally prevalent leptospira serovar in the philippines | |
AR093424A1 (en) | ATTACHED VACCINES OF HAEMOLYTIC MANNHEIMIA AND METHODS FOR THEIR ELABORATION AND USE | |
MX362420B (en) | Polyvalent fusion protein vaccine against influenza. | |
CO6160333A2 (en) | BATTERIES TREATED WITH HEAT AND EMULSION VACCINES PREPARED FROM THESE BATTERIES TREATED WITH HEAT | |
MX2021015938A (en) | Porcine reproductive and respiratory syndrome vaccine virus. | |
EA202090236A1 (en) | IMMUNOGENIC COMPOSITIONS OF SENECAVIRUS A AND WAYS WITH THEM | |
UA127237U (en) | Pig Leptospirosis Vaccine (SUIS Option) | |
UA127236U (en) | LIPTOSPIROSIS VACCINE POLYVALENT (BOVIS OPTION) |